Publication:
PCSK5 mutation in a patient with the VACTERL association

Thumbnail Image

Open/View Files

Date

2015

Journal Title

Journal ISSN

Volume Title

Publisher

BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Nakamura, Y., S. Kikugawa, S. Seki, M. Takahata, N. Iwasaki, H. Terai, M. Matsubara, et al. 2015. “PCSK5 mutation in a patient with the VACTERL association.” BMC Research Notes 8 (1): 228. doi:10.1186/s13104-015-1166-0. http://dx.doi.org/10.1186/s13104-015-1166-0.

Research Data

Abstract

Background: The VACTERL association is a typically sporadic, non-random collection of congenital anomalies that includes vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula with esophageal atresia, renal anomalies, and limb abnormalities. Although several chromosomal aberrations and gene muta tions have been reported as disease-causative, these findings have been sparsely replicated to date. Case presentation: In the present study, whole exome sequencing of a case with the VACTERL association uncovered a novel frameshift mutation in the PCSK5 gene, which has been reported as one of the causative genes for the VACTERL association. Although this mutation appears potentially pathogenic in its functional aspects, it was also carried by the healthy father. Furthermore, a database survey revealed several other deleterious variants in the PCSK5 gene in the general population. Conclusions: Further studies are necessary to clarify the etiological role of the PCSK5 mutation in the VACTERL association. Electronic supplementary material The online version of this article (doi:10.1186/s13104-015-1166-0) contains supplementary material, which is available to authorized users.

Description

Keywords

VACTERL association, Whole exome sequencing

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories